APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Embryonic Stem Cells (HESC)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Human Embryonic Stem Cells (HESC) Industry Research Report 2026

27 December 2025131 pages

Choose your research edition.

Industry ResearchHuman Embryonic Stem Cells (HESC) Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Embryonic Stem Cells (HESC) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Human Embryonic Stem Cells (HESC) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Embryonic Stem Cells (HESC) Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Embryonic Stem Cells (HESC) Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Human Embryonic Stem Cells (HESC) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Human Embryonic Stem Cells (HESC) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Human Embryonic Stem Cells (HESC) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Human Embryonic Stem Cells (HESC) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, Viacyte, Inc., UK Stem Cell Bank, TATAA Biocenter, Takara Bio, STEMCELL Technologies, Reliance Life Sciences and R&D Systems (Biotrchne), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Human Embryonic Stem Cells (HESC) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Embryonic Stem Cells (HESC) Market by Company

ESI BIO

Thermo Fisher

Viacyte, Inc.

UK Stem Cell Bank

TATAA Biocenter

Takara Bio

STEMCELL Technologies

Reliance Life Sciences

R&D Systems (Biotrchne)

PerkinElmer

MilliporeSigma (Merck)

Fujifilm Cellular Dynamics

BioTime

BD Biosciences

Asterias Biotherapeutics

Astellas Institute of Regenerative Medicine

Human Embryonic Stem Cells (HESC) Segment by Type

Unipotent Stem Cells

Pluripotent Stem Cells

Totipotent Stem Cells

Human Embryonic Stem Cells (HESC) Segment by Application

Research

Clinical Trials

Others

Human Embryonic Stem Cells (HESC) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Embryonic Stem Cells (HESC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Embryonic Stem Cells (HESC) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Embryonic Stem Cells (HESC).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Embryonic Stem Cells (HESC) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Embryonic Stem Cells (HESC) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Embryonic Stem Cells (HESC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Embryonic Stem Cells (HESC) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Embryonic Stem Cells (HESC) Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Embryonic Stem Cells (HESC) Revenue of Manufacturers (2021-2026) Table 9. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Embryonic Stem Cells (HESC) Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Human Embryonic Stem Cells (HESC) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Embryonic Stem Cells (HESC), Product Type & Application Table 14. Global Human Embryonic Stem Cells (HESC) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Embryonic Stem Cells (HESC) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ESI BIO Company Information Table 19. ESI BIO Business Overview Table 20. ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio Table 22. ESI BIO Recent Developments Table 23. Thermo Fisher Company Information Table 24. Thermo Fisher Business Overview Table 25. Thermo Fisher Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio Table 27. Thermo Fisher Recent Developments Table 28. Viacyte, Inc. Company Information Table 29. Viacyte, Inc. Business Overview Table 30. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio Table 32. Viacyte, Inc. Recent Developments Table 33. UK Stem Cell Bank Company Information Table 34. UK Stem Cell Bank Business Overview Table 35. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio Table 37. UK Stem Cell Bank Recent Developments Table 38. TATAA Biocenter Company Information Table 39. TATAA Biocenter Business Overview Table 40. TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio Table 42. TATAA Biocenter Recent Developments Table 43. Takara Bio Company Information Table 44. Takara Bio Business Overview Table 45. Takara Bio Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio Table 47. Takara Bio Recent Developments Table 48. STEMCELL Technologies Company Information Table 49. STEMCELL Technologies Business Overview Table 50. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio Table 52. STEMCELL Technologies Recent Developments Table 53. Reliance Life Sciences Company Information Table 54. Reliance Life Sciences Business Overview Table 55. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio Table 57. Reliance Life Sciences Recent Developments Table 58. R&D Systems (Biotrchne) Company Information Table 59. R&D Systems (Biotrchne) Business Overview Table 60. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio Table 62. R&D Systems (Biotrchne) Recent Developments Table 63. PerkinElmer Company Information Table 64. PerkinElmer Business Overview Table 65. PerkinElmer Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio Table 67. PerkinElmer Recent Developments Table 68. MilliporeSigma (Merck) Company Information Table 69. MilliporeSigma (Merck) Business Overview Table 70. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio Table 72. MilliporeSigma (Merck) Recent Developments Table 73. Fujifilm Cellular Dynamics Company Information Table 74. Fujifilm Cellular Dynamics Business Overview Table 75. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio Table 77. Fujifilm Cellular Dynamics Recent Developments Table 78. BioTime Company Information Table 79. BioTime Business Overview Table 80. BioTime Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. BioTime Human Embryonic Stem Cells (HESC) Product Portfolio Table 82. BioTime Recent Developments Table 83. BD Biosciences Company Information Table 84. BD Biosciences Business Overview Table 85. BD Biosciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio Table 87. BD Biosciences Recent Developments Table 88. Asterias Biotherapeutics Company Information Table 89. Asterias Biotherapeutics Business Overview Table 90. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio Table 92. Asterias Biotherapeutics Recent Developments Table 93. Astellas Institute of Regenerative Medicine Company Information Table 94. Astellas Institute of Regenerative Medicine Business Overview Table 95. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio Table 97. Astellas Institute of Regenerative Medicine Recent Developments Table 98. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Human Embryonic Stem Cells (HESC) Sales by Region (2021-2026) & (K Units) Table 100. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2021-2026) Table 101. Global Human Embryonic Stem Cells (HESC) Sales by Region (2027-2032) & (K Units) Table 102. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2027-2032) Table 103. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2021-2026) Table 105. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2027-2032) Table 107. North America Human Embryonic Stem Cells (HESC) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 109. North America Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 110. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Human Embryonic Stem Cells (HESC) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 114. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 115. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 119. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 120. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Human Embryonic Stem Cells (HESC) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 124. South America Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 125. South America Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Human Embryonic Stem Cells (HESC) Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2026) & (K Units) Table 133. Global Human Embryonic Stem Cells (HESC) Sales by Type (2027-2032) & (K Units) Table 134. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2021-2026) Table 135. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2027-2032) Table 136. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Human Embryonic Stem Cells (HESC) Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2021-2026) Table 139. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2027-2032) Table 140. Global Human Embryonic Stem Cells (HESC) Price by Type (2021-2026) & (US$/Unit) Table 141. Global Human Embryonic Stem Cells (HESC) Price by Type (2027-2032) & (US$/Unit) Table 142. Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2026) & (K Units) Table 143. Global Human Embryonic Stem Cells (HESC) Sales by Application (2027-2032) & (K Units) Table 144. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2021-2026) Table 145. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2027-2032) Table 146. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Human Embryonic Stem Cells (HESC) Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2021-2026) Table 149. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2027-2032) Table 150. Global Human Embryonic Stem Cells (HESC) Price by Application (2021-2026) & (US$/Unit) Table 151. Global Human Embryonic Stem Cells (HESC) Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Human Embryonic Stem Cells (HESC) Distributors List Table 155. Human Embryonic Stem Cells (HESC) Customers List Table 156. Human Embryonic Stem Cells (HESC) Industry Trends Table 157. Human Embryonic Stem Cells (HESC) Industry Drivers Table 158. Human Embryonic Stem Cells (HESC) Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Embryonic Stem Cells (HESC) Product Image Figure 5. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Embryonic Stem Cells (HESC) Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Embryonic Stem Cells (HESC) Sales (2021-2032) & (K Units) Figure 8. Global Human Embryonic Stem Cells (HESC) Average Price (US$/Unit) & (2021-2032) Figure 9. Unipotent Stem Cells Product Image Figure 10. Pluripotent Stem Cells Product Image Figure 11. Totipotent Stem Cells Product Image Figure 12. Research Product Image Figure 13. Clinical Trials Product Image Figure 14. Others Product Image Figure 15. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Human Embryonic Stem Cells (HESC) Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Human Embryonic Stem Cells (HESC) Sales by Region in 2025 Figure 21. Global Human Embryonic Stem Cells (HESC) Revenue by Region in 2025 Figure 22. North America Human Embryonic Stem Cells (HESC) Market Size by Country in 2025 Figure 23. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 24. North America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2021-2032) Figure 25. United States Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Human Embryonic Stem Cells (HESC) Market Size by Country in 2025 Figure 29. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 30. Europe Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2021-2032) Figure 31. Germany Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Human Embryonic Stem Cells (HESC) Market Size by Country in 2025 Figure 42. Asia Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2021-2032) Figure 44. China Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Human Embryonic Stem Cells (HESC) Market Size by Country in 2025 Figure 53. South America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 54. South America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2021-2032) Figure 55. Brazil Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size by Country in 2025 Figure 59. Middle East and Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2021-2032) Figure 61. Egypt Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2021-2032) Figure 67. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2021-2032) Figure 68. Global Human Embryonic Stem Cells (HESC) Price (US$/Unit) by Type (2021-2032) Figure 69. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2021-2032) Figure 70. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2021-2032) Figure 71. Global Human Embryonic Stem Cells (HESC) Price (US$/Unit) by Application (2021-2032) Figure 72. Human Embryonic Stem Cells (HESC) Value Chain Figure 73. Human Embryonic Stem Cells (HESC) Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Human Embryonic Stem Cells (HESC) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Unipotent Stem Cells
  • Pluripotent Stem Cells
  • Totipotent Stem Cells
Applications
  • Research
  • Clinical Trials
  • Others
Companies covered
  • ESI BIO
  • Thermo Fisher
  • Viacyte, Inc.
  • UK Stem Cell Bank
  • TATAA Biocenter
  • Takara Bio
  • STEMCELL Technologies
  • Reliance Life Sciences
  • R&D Systems (Biotrchne)
  • PerkinElmer
  • MilliporeSigma (Merck)
  • Fujifilm Cellular Dynamics
  • BioTime
  • BD Biosciences
  • Asterias Biotherapeutics
  • Astellas Institute of Regenerative Medicine

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Embryonic Stem Cells (HESC) Market Size (2021-2032)
  4. 2.2.2 Global Human Embryonic Stem Cells (HESC) Sales (2021-2032)
  5. 2.2.3 Global Human Embryonic Stem Cells (HESC) Market Average Price (2021-2032)
  6. 2.3 Human Embryonic Stem Cells (HESC) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Unipotent Stem Cells
  9. 2.3.3 Pluripotent Stem Cells
  10. 2.3.4 Totipotent Stem Cells
  11. 2.4 Human Embryonic Stem Cells (HESC) by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Research
  14. 2.4.3 Clinical Trials
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Embryonic Stem Cells (HESC) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Embryonic Stem Cells (HESC) Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Human Embryonic Stem Cells (HESC) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Embryonic Stem Cells (HESC) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Embryonic Stem Cells (HESC) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Embryonic Stem Cells (HESC), Product Type & Application
  8. 3.8 Global Manufacturers of Human Embryonic Stem Cells (HESC), Established Date
  9. 3.9 Global Human Embryonic Stem Cells (HESC) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ESI BIO
  2. 4.1.1 ESI BIO Company Information
  3. 4.1.2 ESI BIO Business Overview
  4. 4.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio
  6. 4.1.5 ESI BIO Recent Developments
  7. 4.2 Thermo Fisher
  8. 4.2.1 Thermo Fisher Company Information
  9. 4.2.2 Thermo Fisher Business Overview
  10. 4.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio
  12. 4.2.5 Thermo Fisher Recent Developments
  13. 4.3 Viacyte, Inc.
  14. 4.3.1 Viacyte, Inc. Company Information
  15. 4.3.2 Viacyte, Inc. Business Overview
  16. 4.3.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio
  18. 4.3.5 Viacyte, Inc. Recent Developments
  19. 4.4 UK Stem Cell Bank
  20. 4.4.1 UK Stem Cell Bank Company Information
  21. 4.4.2 UK Stem Cell Bank Business Overview
  22. 4.4.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio
  24. 4.4.5 UK Stem Cell Bank Recent Developments
  25. 4.5 TATAA Biocenter
  26. 4.5.1 TATAA Biocenter Company Information
  27. 4.5.2 TATAA Biocenter Business Overview
  28. 4.5.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio
  30. 4.5.5 TATAA Biocenter Recent Developments
  31. 4.6 Takara Bio
  32. 4.6.1 Takara Bio Company Information
  33. 4.6.2 Takara Bio Business Overview
  34. 4.6.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio
  36. 4.6.5 Takara Bio Recent Developments
  37. 4.7 STEMCELL Technologies
  38. 4.7.1 STEMCELL Technologies Company Information
  39. 4.7.2 STEMCELL Technologies Business Overview
  40. 4.7.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio
  42. 4.7.5 STEMCELL Technologies Recent Developments
  43. 4.8 Reliance Life Sciences
  44. 4.8.1 Reliance Life Sciences Company Information
  45. 4.8.2 Reliance Life Sciences Business Overview
  46. 4.8.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio
  48. 4.8.5 Reliance Life Sciences Recent Developments
  49. 4.9 R&D Systems (Biotrchne)
  50. 4.9.1 R&D Systems (Biotrchne) Company Information
  51. 4.9.2 R&D Systems (Biotrchne) Business Overview
  52. 4.9.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio
  54. 4.9.5 R&D Systems (Biotrchne) Recent Developments
  55. 4.10 PerkinElmer
  56. 4.10.1 PerkinElmer Company Information
  57. 4.10.2 PerkinElmer Business Overview
  58. 4.10.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio
  60. 4.10.5 PerkinElmer Recent Developments
  61. 4.11 MilliporeSigma (Merck)
  62. 4.11.1 MilliporeSigma (Merck) Company Information
  63. 4.11.2 MilliporeSigma (Merck) Business Overview
  64. 4.11.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio
  66. 4.11.5 MilliporeSigma (Merck) Recent Developments
  67. 4.12 Fujifilm Cellular Dynamics
  68. 4.12.1 Fujifilm Cellular Dynamics Company Information
  69. 4.12.2 Fujifilm Cellular Dynamics Business Overview
  70. 4.12.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio
  72. 4.12.5 Fujifilm Cellular Dynamics Recent Developments
  73. 4.13 BioTime
  74. 4.13.1 BioTime Company Information
  75. 4.13.2 BioTime Business Overview
  76. 4.13.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 BioTime Human Embryonic Stem Cells (HESC) Product Portfolio
  78. 4.13.5 BioTime Recent Developments
  79. 4.14 BD Biosciences
  80. 4.14.1 BD Biosciences Company Information
  81. 4.14.2 BD Biosciences Business Overview
  82. 4.14.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio
  84. 4.14.5 BD Biosciences Recent Developments
  85. 4.15 Asterias Biotherapeutics
  86. 4.15.1 Asterias Biotherapeutics Company Information
  87. 4.15.2 Asterias Biotherapeutics Business Overview
  88. 4.15.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio
  90. 4.15.5 Asterias Biotherapeutics Recent Developments
  91. 4.16 Astellas Institute of Regenerative Medicine
  92. 4.16.1 Astellas Institute of Regenerative Medicine Company Information
  93. 4.16.2 Astellas Institute of Regenerative Medicine Business Overview
  94. 4.16.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio
  96. 4.16.5 Astellas Institute of Regenerative Medicine Recent Developments
5 Global Human Embryonic Stem Cells (HESC) Market Scenario by Region
  1. 5.1 Global Human Embryonic Stem Cells (HESC) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2021-2032
  3. 5.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2021-2026
  4. 5.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2027-2032
  5. 5.3 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2027-2032
  8. 5.4 North America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country
  9. 5.4.1 North America Human Embryonic Stem Cells (HESC) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  11. 5.4.3 North America Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country
  16. 5.5.1 Europe Human Embryonic Stem Cells (HESC) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  18. 5.5.3 Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Human Embryonic Stem Cells (HESC) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country
  41. 5.7.1 South America Human Embryonic Stem Cells (HESC) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  43. 5.7.3 South America Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2032)
  2. 6.1.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Embryonic Stem Cells (HESC) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2032)
  2. 7.1.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Embryonic Stem Cells (HESC) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Embryonic Stem Cells (HESC) Value Chain Analysis
  2. 8.1.1 Human Embryonic Stem Cells (HESC) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Embryonic Stem Cells (HESC) Production Mode & Process
  5. 8.2 Human Embryonic Stem Cells (HESC) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Embryonic Stem Cells (HESC) Distributors
  8. 8.2.3 Human Embryonic Stem Cells (HESC) Customers
9 Global Human Embryonic Stem Cells (HESC) Analyzing Market Dynamics
  1. 9.1 Human Embryonic Stem Cells (HESC) Industry Trends
  2. 9.2 Human Embryonic Stem Cells (HESC) Industry Drivers
  3. 9.3 Human Embryonic Stem Cells (HESC) Industry Opportunities and Challenges
  4. 9.4 Human Embryonic Stem Cells (HESC) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst